Ares Systematic Credit »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ares Systematic Credit

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ares Systematic Credit from 13F filings

Historical chart of Ares Systematic Credit investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Ares Systematic Credit consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Ares Systematic Credit

Quarter filed Position value Share count Share price at filing
2026-03-31 $125k 100k 1.25
2025-12-31 $133k 100k 1.33